Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Tenax Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +2 vs. Q1 2024
- Shares held
- 18.8K
- +11.6K (+160.3%) vs. Q1 2024
- Total value
- $57.2K
- +$26.7K (+87.4%) vs. Q1 2024
- New holders
- 4
- 2 more added
- Sold out
- 2
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 11,041 | $33.6K | 0.00% | +11,041 | New |
| Qube Research & Technologies Ltd | 4,407 | $13.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,499 | $4.52K | 0.00% | +115+8.3% | Added |
| Tower Research Capital LLC (TRC) | 961 | $2.90K | 0.00% | +424+79.0% | Added |
| CIBC Private Wealth Group, LLC | 343 | $1.09K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 300 | $904 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 260 | $784 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 16 | $48 | 0.00% | +16 | New |
| Allworth Financial LP | 1 | $4 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $3 | 0.00% | +1 | New |
| Royal Bank of Canada | 1 | $0 | 0.00% | +1 | New |
| Wells Fargo & Company | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Tucker Asset Management LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |